Earnings Season Wrap-Up: Health Insurance Stocks Performance
As the earnings season comes to a close, it’s a good moment to reflect on which health insurance companies performed well and which struggled. Let’s dive into how some of the industry’s leading stocks fared in the fourth quarter.
Health insurers rely heavily on the upfront premiums they collect for steady revenue. However, their profits hinge on accurately assessing risks and managing medical costs. The industry is also affected by changes in regulations and economic factors like unemployment. Looking ahead, the sector could benefit from an aging population, a growing need for personalized healthcare, and advancements in data management for cost-efficiency. At the same time, ongoing scrutiny over pricing practices, potential government healthcare reforms, and rising medical costs could create uncertainty in profit margins. An emerging conversation among investors revolves around the long-term effects of AI, particularly in underwriting and claims processing, and whether it will introduce ethical challenges or worsen biases in healthcare.
During the latest quarter, the 12 health insurance companies we monitor reported a slower performance overall. While they exceeded analysts’ revenue expectations by 0.8%, forecasting for the next quarter remained consistent.
Despite these numbers, share prices have taken a hit. On average, stocks in this sector are down by 13.2% since the earnings results were announced.
UnitedHealth Group (NYSE: UNH)
UnitedHealth Group serves over 100 million people and employs more than 400,000 staff members. The company combines its health insurance services with Optum, which provides various healthcare services.
In the last quarter, UnitedHealth reported revenues of $113.2 billion, representing a 12.3% increase from the previous year. While this met analysts’ expectations, it was generally considered a lackluster quarter, particularly because the company’s full-year revenue guidance fell short of expectations. CEO Stephen Hemsley remarked, “We confronted challenges directly and emerged from 2025 as a stronger company, enabling us to provide better services to those who rely on us.”
Currently, the stock is down 22.3% since the earnings report and trades at $273.40.
Clover Health (NASDAQ: CLOV)
Founded in 2014 to enhance healthcare for seniors in America, Clover Health specializes in Medicare Advantage plans. The company leverages its Clover Assistant software to assist doctors in patient management.
Clover Health reported revenues of $487.7 million, showing a significant 44.7% year-on-year growth, and surpassed analysts’ estimates by 4.4%. Despite the impressive results, the stock is down 21.2% since the announcement, now trading at $1.70.
Molina Healthcare (NYSE: MOH)
Established in 1980, Molina Healthcare focuses on providing managed services to low-income individuals through Medicaid and Medicare programs across 21 states.
Molina reported revenues of $11.38 billion, an 8.3% increase from last year, beating analysts’ expectations by 3.7%. However, the company fell short in its full-year revenue guidance. Consequently, the stock has declined by 24% since the results were issued, currently trading at $134.38.
Centene Corporation (NYSE: CNC)
Centene serves about one in fifteen Americans through government-sponsored health programs. The company reported revenues of $49.73 billion, a 21.9% increase from the prior year, exceeding forecasts by 3%. Still, the company lost 334,600 customers, bringing its total to 27.63 million. The stock has dropped 14.2% since its earnings release and currently trades at $34.25.
Oscar Health (NYSE: OSCR)
Founded in 2012, Oscar Health aims to simplify the American healthcare system with its technology-driven approach to health insurance.
In the latest quarter, Oscar Health reported revenues of $2.81 billion, a 17.3% year-on-year growth, but missed analysts’ expectations by 10.2%. The stock has decreased by 7.2% since the announcement, currently priced at $11.74.
Market Overview
The end of 2025 and the beginning of 2026 saw worries around the implications of artificial intelligence. Concerns ranged from its ability to compress margins in software sectors to its potential risks in trading and crypto markets. As certain stocks were shunned for safer options, market focus then pivoted to geopolitical issues, particularly the heightened tensions with Iran. This shift led investors to reassess risks, focusing on oil supply, inflation, and overall global stability.
For those looking to invest in strong companies, keep an eye on top performers that are likely to thrive regardless of the surrounding economic conditions.
